Clinical TrialID 331

Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder

NCT05013593

Urge Incontinence|Overactive Bladder

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
331
Evidence Id
331
Core Evidence Id
331
Source Clinical Trial Id
317
Herb2 Clinical Trial Id
HBCT000317
Nct Id
NCT05013593
Title
Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder
Status
Completed
Phase
Study Result
No
Study Condition
Urge Incontinence|Overactive Bladder
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: Red Clover Extract (RCE)|OTHER: Placebo (PL)
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Basic_Science
Gender
Female
Age
Adult, Older_Adult
Enrollment
108
Outcome Measure
Change from baseline microbiota composition in women suffering from UUI and OAB at three months follow-up, The microbiota composition is analyzed using sequencing of bacterial DNA. We are investigating the urinary, vaginal and gut microbiota. In women with urge urinary incontinence (UUI) and overactive bladder (OAB) receiving RCE (symptomatic RCE), a possible change in the urinary, vaginal and fecal microbiota composition from baseline to three month follow-up, compared to controls receiving placebo (symptomatic PL) are investigated. Symptomatic RCE from baseline to follow-up vs. Symptomatic PL from baseline to follow-up, From baseline to three months follow-up|Change in baseline microbiota composition at three months follow-up, The microbiota composition is analyzed using sequencing of bacterial DNA. Comparison of healthy women without bladder symptoms receiving RCE (healthy RCE) at baseline to three months follow-up compared to controls (healthy PL) from baseline to follow-up. Healthy RCE from baseline to follow-up vs. Healthy PL from baseline to follow-up, From baseline to three months follow-up|Difference in baseline microbiota composition between women with and without UUI and OAB, The microbiota composition is analyzed using sequencing of bacterial DNA. Is there a difference in the urinary, vaginal and gut microbiota in women with and without urge urinary incontinence (UUI) and overactive bladder (OAB) at baseline? Symptomatic PL baseline vs. Healthy PL baseline, Baseline
Sponsor Collaborator
Vendsyssel Hospital|University of Aarhus
Funded By
OTHER_GOV
Location
North Denmark Regional Hospital (Vendsyssel Hospital), Hjørring, 9800, Denmark
Other Id
N-20190028
Start Date
2019-07-15
Primary Completion Date
2021-10-20
Completion Date
2021-10-20
First Posted
2021-08-19
Results First Posted
Last Update Posted
2023-04-26
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05013593
Title Cn
Title En
Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder
Bilingual Status
semi_complete